Search results
May 5, 2023 · Brain cancer expert Dr. Eric Holland receives Endowed Chair in Cancer Biology. Chair recognizes comprehensive vision, contributions to solid tumor research. May 5, 2023 • By Sabrina Richards / Fred Hutch News Service. Fred Hutch's Dr. Eric Holland was just named the Endowed Chair in Cancer Biology. Fred Hutch file photo.
Phone: 206.667.6117. Email: eholland@fredhutch.org. Fax: 206.667.6022. Dr. Eric Holland is a world-renowned physician-scientist who combines compassionate patient care with exacting laboratory research to discover more effective treatments for brain tumors.
View CV. Dr. Eric Holland is a world-renowned physician-scientist who combines compassionate patient care with exacting laboratory research to discover more effective treatments for brain tumors. As a neurosurgeon, Dr. Holland specializes in caring for patients with glioblastomas, aggressive cancers that are the most common malignant brain ...
Working at the intersection of multiple disciplines, Holland strives to understand the molecular basis of brain tumors and develop new approaches to their treatment. He specializes in the research and treatment of glioblastoma — the most common brain cancer in adults — and metastatic brain tumors.
People also ask
Who is Eric Holland?
Who is Eric Holland and why was he charged with murder?
What does Dr Holland do?
Who is Erin Holland?
Specimen. Dr. Eric Holland is a world-renowned physician-scientist who combines compassionate patient care with exacting laboratory research to discover more effective treatments for brain tumors. As a neurosurgeon, Dr. Holland specializes in caring for patients with glioblastomas, aggressive cancers that are.
Glioblastoma multiforme: the terminator. EC Holland. Proceedings of the National Academy of Sciences 97 (12), 6242-6244. , 2000. 1014. 2000. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.
The Holland lab works at the intersection of multiple disciplines to address the molecular basis of brain tumors and develop new approaches to their treatment. Our research focuses on developing mouse models of brain cancer that mimic the behavior of the disease in patients. Our work with mouse models has led to clinical trials in glioma patients.
